Laboratories ltd, Pharmaceutical company

The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories."The RDIF, Russia's sovereign wealth fund, and Dr. Reddy's Laboratories Ltd. (Dr. Reddy's), a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India. Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine," Sputnik quoted the RDIF's press release.Deliveries could start in late 2020, the release added.GV Prasad, Co-Chairman and Managing Director of Dr. Reddy said that the Phase I and II trials results have shown promise, and the company will be conducting Phase III trials in India to meet the requirements of the Indian regulators."We are pleased to partner with RDIF to bring the vaccine to India. Phase I and II results have shown promise, and we will be conducting Phase III trials in India to meet the requirements of the Indian regulators. Sputnik V vaccine could provide a credible option in our fight against COVID 19 in India," Dr. Reddy's Co-Chairman and Managing Director GV Prasad said, as quoted in the press release.The RDIF is pleased to reach the agreement with the Indian company, the RDIF CEO Kirill Dmitriev said."Dr. Reddy's has had a very well established and respected presence in Russia for over 25 years and is one of the leading pharmaceutical compes in India," he said"India is amongst most severely impacted countries from the novel coronavirus and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against COVID 19. RDIF partners will receive an effective and safe drug to fight the coronavirus," he added.Last week, the Russian Health Ministry announced that the first batch of Sputnik V vaccine against COVID-19 has been released into civil circulation.The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Laboratories Ltd, NewsFOLLOW

Laboratories ltd, Latest News

Health :Dr. Reddy's acquires Mayne Pharma's US prescription portfolio for $105 mn

Chennai, Feb 27 Indian pharma major, Dr. Reddy's Laboratories Ltd, through its subsidiary has inked an agreement to ... ...

Business :Flutura accelerates Lupin to digitally transform their operations using AI

Flutura Business Solutions LLC, an Industrial IoT Intelligence provider, is collaborating with global pharma major Lupin Limited (Lupin) to accelerate its digital transformation and automation journey. ...

Health :Dr Reddy's plans to launch Sputnik V in India in March

Hyderabad, Jan 29 Dr Reddy's Laboratories Ltd hopes to launch Russian Covid vaccine Sputnik V in India in ... ...

Health :Dr Reddy's receives approval for Phase 3 clinical trial of Sputnik vaccine

Hyderabad, Jan 15 Pharma major Dr Reddy's Laboratories Ltd on Friday announced that it has received approval from ... ...

National :Russian COVID vaccine Sputnik V meets primary safety endpoint in phase-2 clinical trials in India

The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement. ...

International :Russia to supply 100 million doses of COVID-19 vaccine to India's Dr. Reddy's Laboratories

The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories. ...